P61.5
Transient neonatal neutropenia
Clinical Classification Guidelines
Excludes Type 1
- congenital neutropenia (nontransient) (D70.0)
Medical Intelligence & Overview
Transient neonatal neutropenia is a condition that affects newborns, characterized by a temporary decrease in neutrophils, a type of white blood cell essential for fighting infections. This condition typically resolves on its own within a few days to weeks and is often identified when blood tests reveal lower-than-normal neutrophil counts. Recognizing this condition is important for differentiating it from other more serious infections or blood disorders in newborns.
Causes & Symptoms
Clinical Causes: Immature immune system of the newborn Birth-related stress or trauma Maternal infections during pregnancy Certain genetic factors Exposure to specific medications or toxins during pregnancy Delayed bone marrow response after birth Transient effects of maternal antibodies
Key Symptoms: Usually no specific symptoms, as it is often detected through blood tests Signs of infection such as fever, lethargy, or irritability (if infection develops) Possible skin or mucous membrane infections due to low neutrophils General pallor or weakness in some cases
Diagnostic & Treatment
Diagnosis Path: Diagnosis primarily involves blood tests that measure the number of neutrophils and other white blood cells. A complete blood count (CBC) can reveal low neutrophil levels, confirming neutropenia. Healthcare providers may also investigate underlying causes through additional testing, including maternal health history, blood cultures, or genetic studies. Importantly, because this condition is temporary, repeated testing may be used to monitor recovery and confirm resolution.
Treatment Protocols: Most cases of transient neonatal neutropenia require no specific treatment as the condition tends to resolve spontaneously. Management focuses on close monitoring for signs of infection and maintaining a sterile environment. If infections occur or neutropenia is severe, antibiotic therapy may be considered. In rare instances, supportive measures such as granulocyte colony-stimulating factor (G-CSF) could be used under specialist guidance. Prevention of infections and prompt treatment if they arise are essential aspects of managing this condition.
Clinical Advice & FAQs
Billing Guidance
Is P61.5 a billable ICD-10 code?
Yes, P61.5 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report P61.5?
Clinical documentation must specify the nature of Transient neonatal neutropenia and any associated comorbidities for accurate reporting.
Cite this Clinical Reference
